Study of Pediatric Migraine: The Pediatric Migraine Registry
NCT ID: NCT03742024
Last Updated: 2021-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
201 participants
OBSERVATIONAL
2018-12-05
2021-02-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
NCT05164172
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
NCT05897320
Treatment of Acute Migraine Headache in Children
NCT00355394
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
NCT04965675
The Evolution and Management of Migraine Recurrence Beyond 24 Hours
NCT00754611
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children and adolescents
Children and adolescents between the ages of 4 and 17 years old (inclusive)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets International Classification of Headache Disorders, 3rd edition criteria for migraine with or without aura
* Guardian provides informed consent/HIPAA
* Participant provides assent if developmentally appropriate and required by the institutional review board
Exclusion Criteria
4 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Hornik, MD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Amy Gelfand, MD
Role: PRINCIPAL_INVESTIGATOR
University of California at San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California at San Francisco
San Francisco, California, United States
Colorado Springs Neurological Associates
Colorado Springs, Colorado, United States
Nemours Alfred I duPont Hospital For Children Neurology
Wilmington, Delaware, United States
Nicklaus Children's Hospital
Miami, Florida, United States
University of Louisville Health Sciences center
Louisville, Kentucky, United States
University of Maryland
Baltimore, Maryland, United States
Michigan Headache & Neurological Institute
Ann Arbor, Michigan, United States
Children's Mercy Hospital
Kansas City, Missouri, United States
Cardinal Glennon Children's Medical Center
St Louis, Missouri, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Akron Children's Hospital
Akron, Ohio, United States
Cincinnati Children's Hospital
Cincinnati, Ohio, United States
The Cleveland Clinic Children's Hospital
Cleveland, Ohio, United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Rhode Island Hospital, The Miriam Hospital
Providence, Rhode Island, United States
University of South Carolina at Columbia
Columbia, South Carolina, United States
University of Vermont School of Medicine
Burlington, Vermont, United States
Seattle Children's Hospital
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00100205
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.